Status:
COMPLETED
Study to Evaluate the Effect of Injection Lypolysis (Lipodissolve) Treatments to Reduce Body Fat
Lead Sponsor:
BodyAesthetic Research Center
Conditions:
Abdominal Subcutaneous Fat
Eligibility:
All Genders
21-65 years
Phase:
NA
Brief Summary
The combination of phosphatidylcholine (PPC) and deoxycholate (DC) injected into subcutaneous fat is often popularly referred to as "Lipodissolve" therapy. Despite its attractiveness as an easy and no...
Eligibility Criteria
Inclusion
- Healthy volunteer
- Body Mass Index (BMI) no greater than 30
- Excess fat in the lower abdomen area
Exclusion
- Cigarette smoker
- Diabetes
- Pregnant or breast feeding
- Use anticoagulants (blood thinner), aspirin or other non-steroidal anti-inflammatory drugs that cannot be discontinued
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00757081
Start Date
June 1 2008
End Date
December 1 2009
Last Update
February 7 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
BodyAesthetic Research Center
Creve Coeur, Missouri, United States, 63141